SYMPOSIUM: PSYCHOTROPIC ANALGESIC NITROUS OXIDE (PAN): MECHANISMS OF ACTION AND USE FOR TREATING SUBSTANCE ABUSE WITHDRAWAL PRESENTED AT 8TH WORLD CONGRESS OF BIOLOGICAL PSYCHIATRY VIENNA (2 JULY 2005) IN MEMORIAM FREDERICK J LICHTIGFELD (1933–2005)

REFERENCES

• Alho H., Methuen T., Paloheimo M., Strid N., Seppa K., Tiainen J., Salaspuro M., Roine R. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: A double-blind, placebo-controlled trial. Alcoholism: Clinical Experimental Research 2002; 26: 1816–1822, [CSA]
   PubMed Web of Science ®Google Scholar
• Alho H., Metheun T., Paloheimo M., Seppä K., Strid N., Apter-Kaseva N., Tiainen K., Salaspuro M., Roine R. Nitrous oxide has no effect in the treatment of alcohol withdrawal syndrome: double-blind placebo-controlled randomized trial. Journal of Clinical Psychopharmacology 2003; 23: 211–214, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Anonymous. Editorial. Pain perception and the placebo response. South African Journal of Science 1987; 83: 519, [CSA]
   Google Scholar
• Bayrakdarian C. Effectiveness of Nitrous Oxide (N20) in reducing cigarette smoking in subjects with nicotine dependence. American Psychiatric Association Meeting. 2000, p. 2 h.
   Google Scholar
• Berlin I., Gorelick D., Thibaut F., Lejoyeux M. Recent advances in biological treatment of addiction. World Journal of Biological Psychiatry 2005; 6(Supplement 1)154–155, [CSA]
   Google Scholar
• Bredt D. S., Snyder S. H. Nitric oxide: A physiologic messenger molecule. Annual Reviews in Biochemistry 1994; 63: 175–195, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Clark M. S., Campbell S. A., Clark A. M. Technique for the administration of nitrous oxide/oxygen sedation to ensure psychotropic analgesic nitrous oxide (PAN) effects. International Journal of Neuroscience 2006; 116: 871–877, [CSA]
   Web of Science ®Google Scholar
• Daynes G., Gillman M. A. Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco. International Journal of Neuroscience 1994; 76: 13–16, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Gillman M. A. Nitrous oxide as neurotransmitter. Lancet 1992a; 339: 307, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gillman M. A. Nitrous oxide, nitric oxide and neurotransmission. British Medical Journal 1992b; 305: 1368, [CSA]
   Google Scholar
• Gillman M. A. Envy as a retarding force in science. Avebury, AldershotU. K 1996
   Google Scholar
• Gillman M. A. Discovery of gasotransmission. The Scientist 2004; 18: 10, [CSA]
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. Paradoxical effect of naloxone on nitrous oxide analgesia in man. European Journal of Pharmacology 1980; 61: 175–177, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. Naloxone in Anorexia Nervosa—The role of the opiate system. Journal of the Royal Society of Medicine 1981; 74: 631–632, [INFOTRIEVE], [CSA]
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. The effect of nitrous oxide and naloxone on orgasm in human females. A preliminary report. Journal of Sex Research 1983; 19: 49–57, [CSA]
   Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. The opioid and anti-opioid system in addiction. South African Medical Journal 1984; 66: 592, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. The opioids, dopamine cholecystokinin and eating disorders. Clinical Neuropharmacology 1986; 9: 91–97, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. Analgesic nitrous oxide for alcohol withdrawal: A critical appraisal after 10 years use. Postgraduate Medical Journal 1990; 66: 543–546, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. The opioid effects of analgesic (subanesthetic) nitrous oxide on the alcohol withdrawal state. New York Academy of Sciences 1991; 625: 784–785, [CSA]
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. Opioid properties of psychotropic analgesic nitrous oxide (laughing gas). Perspectives in Biology and Medicine 1994a; 38: 125–138, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. NO comments. Nature 1994b; 367: 28, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gillman M. A., Lichtigfeld F. J. Randomised double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state. Journal of Substance Abuse Treatment 2002; 22: 129–134, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. Correct use of analgesic nitrous oxide for the alcohol withdrawal state essential. Journal of Clinical Psychopharmacology 2004; 24: 238–239, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gillman M. A., Harker N., Lichtigfeld F. J. Combined cannabis/methaqualone withdrawal treated with psychotropic analgesic nitrous oxide. International Journal of Neuroscience 2006a; 116: 859–869, [CSA]
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J., Harker N. Psychotropic analgesic nitrous oxide for acute cocaine withdrawal in man. International Journal of Neuroscience 2006b; 116: 847–857, [CSA]
   PubMed Web of Science ®Google Scholar
• Kosobud A. Ex˙ K., Kebabian C. E., Rebec G. V. Nitrous oxide acutely suppresses ethanol consumption in HAD and P rats. International Journal of Neuroscience 2006; 116: 835–845, [CSA]
   Web of Science ®Google Scholar
• Lichtigfeld F. J. Mixed anaerobic infection in minor trauma. South African Medical Journal 1967; 41: 222–224, [INFOTRIEVE], [CSA]
   Google Scholar
• Lichtigfeld F. J. Iatrogenic radiation damage and its therapy. Strahlentherapie 1971; 142: 681–685, [INFOTRIEVE], [CSA]
   Google Scholar
• Lichtigfeld F. J. The role of the boundary situation as an illuminating factor for Jaspers' writings on psychopathology. Tijdschrift voor Filosofie 1972; 34: 99–106, [CSA]
   Google Scholar
• Lichtigfeld F. J. Therapy of radiation bowel damage. South African Medical Journal 1987; 71: 467, [INFOTRIEVE], [CSA]
   Google Scholar
• Lichtigfeld F. J. Israel denied the right to defend itself. Sunday Independent. South Africa 2004, 15 August, p. 9.
   Google Scholar
• Lichtigfeld F. J., Gillman M. A. The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. South African Medical Journal 1982; 61: 349–351, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lichtigfeld F. J., Gillman M. A. The effect of placebo in the alcohol withdrawal state. Alcohol and Alcoholism 1989; 24: 109–112, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lichtigfeld F. J., Gillman M. A. Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide (PAN) in alcohol and drug withdrawal. Clinical Neuropharmacology 1996; 19: 246–250, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lichtigfeld F. J., Gillman M. A. Violence and the provision of community psychiatry. Lancet 2000; 355: 1804, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Ojutkangas R. Psychotropic analgesic nitrous oxide: Rapid safe therapy for addictive withdrawal. Postgraduate Medical Journal 1991; 67: 1027–1028, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ojutkangas R. Pioneering PAN in Finland for withdrawal: Success despite biased opposition. World Journal of Biological Psychiatry 2005; 6(Supplement 1)150, [CSA]
   Google Scholar
• Sugerman A. A., Lichtigfeld F. J., Hermann J. A pilot study of clopenthixol. Current Therapeutic Research 1966; 8: 220–224, [INFOTRIEVE], [CSA]
   Google Scholar